Maia H. Harris

Maia focuses her practice on intellectual property litigation and counseling, covering all aspects of intellectual property strategy. This includes strategic counseling at the beginning of product development, commercial transactions involving intellectual property rights, including licensing and joint development agreements, and intellectual property disputes. Maia’s client work spans a variety of industries and technologies, including pharmaceuticals, medical devices, food and beverage, universities and research institutions, and semiconductor manufacturing.

Her counseling and transactional practice includes strategic portfolio analysis, diligence, and commercial transactions involving IP rights such as licensing and joint development agreements.

In litigation, Maia is experienced at representing clients in large-scale complex patent and intellectual property litigation, including in international arbitration and federal district courts across the U.S. Maia has also litigated abbreviated new drug application (ANDA) actions and pharmaceutical patents. Many of these matters have involved significant drug products, and she has worked with internationally renowned experts, conducted Markman hearings and trials, and consulted with clients on antitrust, FDA, and settlement strategies.

Maia’s work also extends to the unique IP issues faced by inventors and companies in startup and research communities. She and other members of the IP team provides a full suite of IP services specific to the needs of universities and research institutions (and related startups), including prosecution and portfolio management and strategy, licensing, and enforcement when necessary.

Litigation

• Represented a medical device manufacturer in a domestic arbitration involving dispute over royalties and IP ownership rights.
• Represented a pharmaceutical client in Prime European Therapeuticals, S.p.A. v. Novel Laboratories, Inc. et al., Civil Action No. 3:17-cv-01944 (D.N.J.).
• Represented a retail entity in a patent infringement matter involving a product provided by three separate manufacturers.
• Represented a software manufacturer in trade secret litigation.
• Represented a medical device manufacturer in a global dispute with a foreign distributor, including international arbitration related to distribution agreement terms, a U.S. District Court case involving trade secret misappropriation, and foreign patent litigation involving infringement allegations and related patent invalidity challenges.
• Represented a pharmaceutical client in Abbott Laboratories v. Biovail Laboratories International SRL et al., Civil Action No. 2:09-cv-00005 (D.N.J.) (ANDA).
• Represented a university in a dispute with and between university licensees.
• Represented a research institution in international arbitration over ownership and licensing rights to patents involving semiconductor technology.
• Obtained favorable pre-trial resolutions in patent infringement matters involving thin film deposition technology.
• Obtained early and favorable resolution to patent infringement matter on behalf of a medical device manufacturer in case involving surgical method patents owned by a university.
• Represented a pharmaceutical client in Elan Pharma International Ltd. v. Biovail Laboratories International SRL et al., Civil Action No. 08-cv-05412 (D.N.J.) (ANDA).
• Represented a respondent in a Section 337 investigation before the ITC involving laser ablation technology; investigation terminated upon complainant’s withdrawal of claims.
• Represented an equipment manufacturer in a patent infringement matter involving analytical instruments; case resolved before Markman hearing.
• Obtained a favorable jury verdict in a patent infringement matter on behalf of a medical device manufacturer enforcing its patents in a case involving surgical methods.
• Obtained a favorable jury verdict in a patent matter against a non-practicing entity in the Eastern District of Virginia in case involving wireless technology.
• Represented a pharmaceutical client in Abbott Laboratories v. Biovail Laboratories International SRL et al., Civil Action No. 1:08-cv-06274 (N.D.IL.) (ANDA).
• Obtained a favorable finding of non-obviousness after a bench trial involving silver halide film patents.
• Represented a telecommunications provider in a patent infringement matter involving VOIP technology; case settled on favorable terms upon transfer of venue from Eastern District of Virginia to the client’s home district.

Transactions, Counseling, and Conflict Resolution

• Strategic review of IP portfolios for prospective protection, potential enforcement, and licensing opportunities.
• Assistance with IP due diligence related to potential transactions and/or licensing offers.
• Advice and counsel on drafting and management of confidentiality obligations as part of joint development projects or other collaborative relationships.
• IP licensing advice, counsel, strategy, and negotiations.
• Pre-litigation advice, counsel, and dispute resolution related to ownership, infringement, and licensing disputes.
• Advice and counsel on IP strategy and information disclosure practices for early-stage companies.

• Boston Magazine, Top Lawyers List, Intellectual Property Rights (2022)
• Managing Intellectual Property: IP Star (2013, 2014, 2017, 2019-2022)
• IP Stars-Top 250 Women in IP (2013, 2014)
• Selected for inclusion on the 2005-07 Massachusetts Rising Stars lists